Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects
Ranjan P Malhotra,1 Edward Meier,2 Gail Torkildsen,3 Paul J Gomes,4 Mark C Jasek5 1Ophthalmology Associates, St Louis, MO, USA; 2Apex Eye, Mason, OH, USA; 3Andover Eye, Andover, MA, USA; 4Ora, Inc., Andover, MA, USA; 5Eyevance Pharmaceuticals, Fort Worth, TX, USA Purpose: The studies reported here...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/caff7eba4c7749339fa7884f74f90a87 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|